Biophysics of DNA-antibiotic complexes

Biophysics of DNA-Antibiotic Complexes

Volumn , Issue , 2011, Pages 1-170

  Vekshin, Nikolai ^a  

^a RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891968461     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (215)

1. Planeles, HH. Aurantin is Anti-tumor Antibiotic Drug of the Group of Actinomycins. Moscow: Mir, 1962.
2. Terent'eva, TG. Drugs and radiation therapy of tumors Khim.- pharmacist. Zh. 1977, 11, 143-146.
3. Frolkis, VV. Aging and Prolongation of Life. Leningrad: Nauka, 1988.
4. Sazykin, Yu. Biochemical Basis of Action of Antibiotics on Microbial Cells. Moscow: Nauka, 1965.
5. Egorov, NS; Silaev, AB; Katrukha, GS. Antibiotics-polypeptides. Moscow: MGU, 1987.
6. Gursky, GV. The structure of complex DNA-actinomycin. Molekilarnaya Biologia, 1969, 3, 749-756.
7. Waksman, S. Actinomycins-nature, production, activities. Rev. Soc. Mex. Hist. Nat. 1969, 30, 301-306.
8. Frei, E. The clinical use of actinomycin. Cancer Chemother. Rep. 1974, 58, 49-54.
9. Maksimova, TS; Kovsharova, JH. Antibiotiki. Antibiotics from Streptomyces parvullis. 1964, 9, 110-115.
10. Vinogradova, KA; Poltorak, VA; Petrova, LI; Silaeva, AB. Producing of antibiotics from Actinomycetes. Antibiotiki. 1970, 15, 718-721.
11. Kuznetsov, VD; Poltorak, VA; Filippova, SN. Active producing of antibiotics with a fixed qualitative composition from Actinomycetes of the Streptomyces genus. Antibiotiki 1973, 18, 431-.
12. Bostian, M; McNitt, K; Aszalos, A; Berdy, J. Antibiotic identification: a computerized data base system. J. Antibiot. (Tokyo) 1977, 3, 634-.
13. Haese, A; Keller, U. Genetics of actinomycin C production in Streptomyces chrysomallus. J. Bacteriol. 1988, 170, 1360-1368.
14. Shaposhnikov, VN; Nefelova, MV. Aurantin. Moscow: Nauka, 1962.
15. Sivak, A; Van Duuren, B. Studies with carcinogens and tumorpromoting agents in cell culture. Exp. Cell. Res. 1968, 49, 572-583.
16. Keller, U. Actinomycin synthetases. Multifunctional enzymes responsible for the synthesis of the peptide chains of actinomycin. J. Biol. Chem. 1987, 25, 5852-5866.
17. Muxfeldt, H; Shrader, S; Hansen, P; Brockman, H. The structure of pikromycin. J. Am. Chem. Soc. 1968, 14, 4748-4749.
18. Terenin, AN. Photonics of Dye Molecules. Leningrad: Nauka, 1967.
19. Savintsev, IV; Vekshin, NL. Non-stacking binding of 7-aminoactinomycin D and actinomycin D with DNA and model nucleotide systems in solutions. Molecularnaya Bioljgia, 2001, 36, 725-730.
20. Paoletti, J; Le Recq, JB. Resonance energy transfer between ethidium bromide molecules bound to nucleic acids. Does intercalation wind or unwind the DNA helix? J. Mol. Biol. 1971, 59, 43-51.
21. Goldberg, H; Reich, E. Actinomycin inhibition of RNA synthesis directed by DNA. Federat. Proc. 1964, 23, 958-964.
22. Jain, SC; Sobell, HM. Stereochemistry of actinomycin binding to DNA. I. Refinement and further structural details of the actinomycindeoxyguanosine crystalline complex. J. Mol. Biol. 1972, 14, 1-20.
23. Sobell, HM; Jain SC. Stereochemistry of actinomycin binding to DNA. II. Detailed molecular model of actinomycin-DNA complex and its implications. J. Mol. Biol. 1972, 68, 21-34.
24. Sobell, HM; Jain, SC; Sakore, TD; Nordman, CE. Stereochemistry of actinomycin-DNA binding. Nat. New. Biol. 1971, 16, 200-205.
25. Pigram, WJ; Fuller, W; Hamilton, LD. Stereochemistry of intercalation: interaction of daunomycin with DNA. Nat. New. Biol. 1972, 5, 17-19.
26. Wadkins, RM; Jovin, TM. Actinomycin D and 7- aminoactinomycin D binding to single-stranded DNA. Biochemistry, 1991, 3, 9469-9478.
27. Vekshin, N; Savintsev, I; Kovalev A; Yelemessov R; Wadkins, R. Solvatochromism of the excitation and emission spectra of 7- aminoactinomycin D: implications for drug recognition of DNA secondary structures. J. Phys. Chem.: B. 2001, 105, 8461-8467.
28. Wadkins, RM., Vladu B., Tunng C. Actinomycin D Binds to metastable hairpins in single-stranded DNA. Biochemistry, 1998, 37, 11915-11923.
29. Wadkins, RM; Tunng, C; Vallone, PM; Benight, AS. The role of the loop in binding of an actinomycin D analog to hairpins formed by single-stranded DNA. Archiv. Biochem. Biophys., 2000, 384, 199-203.
30. Muller, W; Crothers, DM. Studies of the binding of actinomycin and related compounds to DNA. J. Mol. Biol. 1968, 28, 251-290.
31. Tsai, CC; Jain, SC; Sobell, HM. Drug-nucleic acid interaction: X-ray crystallographic determination of an ethidium-dinucleoside monophosphate crystalline complex, ethidium: 5-iodouridylyl(3'-5')adenosine. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 1975, 6, 137-146.
32. Moroshkina, EB; Yudin, IG; Krivtsov, MA; Glibin, EB. Interaction of DNA with amides of actinocin, containing radicals in amid groups. Molecularnaya Biologia, 2000, 34, 448-455.
33. Moroshkina, EB; Yudin, IG; Krivtsov, MA; Glibin, EB. Interaction of DNA with ampholites on the basis of actinocin. Molecularnaya Biologia, 1998, 32, 652-656.
34. Krugh, T. Association of actinomycin D and deoxyribodinucleotides as a model for binding of the drug to DNA. Proc. Nat. Acad. Sci. USA. 1972, 69, 311-314.
35. Schara, R; Muller, W. Binding of actinomycin C 3 to mono, di, and oligonucleotides. Eur. J. Biochem. 1972, 29, 210-216.
36. Chinsky, L; Turpin PY. / / Nucleic Acids Res. 1978, 5(8) 2969-2977.
37. Krivtsov, MA; Moroshkina, EB; Hammana, H; Glibin, EB; Frisman, EV. / / Molekularnaya Biologia, 1981, 15, 613-621.
38. Nikitin, SM; Zhuze, AL; Krylov, AS; Gottikh, BP. Ligands, having an affinity to define pairs of bases DNA. Analogues of actinomycin D. Bioorganicheskaya Chkimiya. 1980, 6, 743-751.
39. Krivtsova, MA; Moroshkina, EB; Glibin, EB; Frisman, EV. Interaction of DNA with small ligands of different structure. Complexes DNA with actinomycin and its analogues. Molekularnaya Biologia 1982, 16, 155-.
40. Kersten, W; Kersten, H; Szybalcky, W. Physiochemical properties of complexes between deoxyribonucleic acids and antibiotic which effect ribonucleic acid synthesis. Biochemistry, 1966, 5, 236-244.
41. Permogorov, VI; Prozorov, AA; Shemyakin, MF; Lazurkin, NS; Khesin, RB. On the mechanism of suppression of biological activity of DNA by actinomycin. In: Molecular Physics. Moscow: Nauka, 1965, 162-180.
42. Chen, FM; Jones, CM; Johnson, QL. Dissociation kinetics of actinomycin D from oligonucleotides with hairpin motifs. Biochemistry. 1993, 32, 5554-5559.
43. Bittman, R; Blau, L. Stopped-flow kinetic studies of actinomycin binding to DNAs. Biochemistry, 1975, 14, 2138-2145.
44. Kolesnikov, DV; Zhuze, AL; Zasedatelev AS. DNA-specific Lowmolecular Compounds. Moscow: MFTI, 1998.
45. Tsai, CC; Jain, SC; Sobell, HM. X-ray crystallographic visualization of drug-nucleic acid intercalative binding: structure of an ethidiumdinucleoside monophosphate crystalline complex, Ethidium: 5- iodouridylyl (3'-5')adenosine. Proc. Natl. Acad. Sci. USA, 1975, 72, 628-632.
46. Kamitori, S; Takusagawa, F. Crystal structure of the 2:1 complex between d(GAAGCTTC) and the anti-cancer drug actinomycin D. J. Mol. Biol. 1992, 20-225(2), 445-456.
47. Veselkov, DA; Kodintsev, VV; Pakhomov, VI. 1H-NMR analysis of heteroassociation of caffeine with antibiotic actinomycin D in the aqueous solution. Biofizika, 2000, 45(2), 197-206.
48. Hou, MH; Robinson, H; Gao, YG; Wang, AH. Crystal structure of actinomycin D bound to the CTG triplet repeat sequences linked to neurological diseases. Nucleic Acids Res. 2002, 15, 4910-4917.
49. Sazykin, JO. Antibiotics as Inhibitors of Biochemical Processes. Moscow: Nauka, 1968.
50. Sazykin, YO; Borisova, GN. Action of specific inhibitors on synthesis of RNA in bacterial cells, uncoupled by antibiotics from protein synthesis. Antibiotiki, 1963, 8, 304-309.
51. Gomatos, P; Krug, R; Tamm, I. Reovirus RNA-directed synthesis of DNA. J. Mol. Biol. 1965, 13, 802-816.
52. Chen, F; Sha, F; Chin, K; Chou S. Unique actinomycin D binding to self complementary d(CXYGGCCY'X'G) sequences: duplex disruption and binding to a nominally base-paired hairpin. Nucleic. Acids Res. 2003, 15, 4238-4246.
53. Brown, D., Kurz, M., Kearns, D., Hsu, V. Formation of multiple complexes between actinomycin D and a DNA hairpin: structural characterization by multinuclear NMR. Biochemistry, 1994, 25, 651-664.
54. Rill, RL; Hecker, KH. Sequence-specific actinomycin D binding to single-stranded DNA inhibits HIV reverse transcriptase and other polymerases. Biochemistry, 1996, 19, 3525-3533.
55. Hsieh, YL; Li, YT; Henion, JD; Ganem, B. Studies of non-covalent interactions of actinomycin D with single-stranded oligodeoxynucleotides by ion spray mass spectrometry and tandem mass spectrometry. Biol. Mass. Spectrom. 1994, 23, 272-276.
56. Sobell, H. Actinomycin and DNA transcription. Proc. Natl. Acad. Sci. USA. 1985, 82, 5328-5331.
57. Sinha, B; Cox, M; Chignell, CF; Cysyk, RL. Synthesis and biological properties of N2-substituted spin-labeled analogues of actinomycin D. J. Med. Chem. 1979, 22, 1051-1055.
58. Sinha, BK; Chignell, CF. Interaction of antitumor drugs with human erythrocyte ghost membranes and mastocytoma P815: a spin label study. Biochem. Biophys. Res. Commun. 1979, 28, 1051-1057.
59. Sinha, B; Cox, M. Stimulation of superoxide formation by actinomycin D and its N2-substituted spin-labeled derivatives. Mol. Pharmacol. 1980, 17, 21-37.
60. Wheeler, GP; Bennett, LL. Studies related to the mode of action of actinomycin D. Biochem. Pharmacol. 1962, 11, 353-370.
61. Krylov, AS. Physiological effects of actinomycins. Antibiotiki, 1982, 27, 221-233.
62. Kersten W., Kersten H., Rauen H. Action of Nucleic Acids on the Inhibition of Growth by Actinomycin of Neurospora crassa. Nature, 1960, 187(473), 60-61.
63. Kawamata, J; Imanishi, M. Action of nucleic acids of the inhibition of growth by actinomycin D of Neurospora crasa. Nature, 1960, 187, 1112-1113.
64. Kawamata, J; Imanishi, M. Mechanism of action of actinomycin with deoyxiribonucleic acids. Biken's J. 1961, 4, 13-24.
65. Fraccaro, M; Mannini, A; Tiepolo, L; Albertini, A. Incorporation of tritium-labelled actinomycin in human cell line. Exptl. Cell. Res., 1966, 43, 136-147.
66. Kawamata, J; Okudaira, M; Akamatsu, Y. Autografic studies on the intracellular distribution of H3- actinomycin S in TG-cells. Biken's J. 1965, 8, 119-127.
67. Bingman, G; Sporn, C. Actinomycine D and hydrocortisone: intracellular binding in rat liver. Science. 1965, 49, 1251-1254.
68. Becker, FF; Margolis, AA; Troll, W. In vivo complex formation of actinomycin D and deoxyribonucleic acid. Nature. 1966, 2, 84-85.
69. Gellert, M; Smith, C; Neville, D. Actinomycin binding to DNA: mechanism and specificity. J. Mol. Biol. 1965, 11, 445-457.
70. Goldberg, I; Rabinowitz, M; Reich, E. Basis on actinomycin action. Proc. Nat. Acad. Sci. USA. 1962, 48, 2094-2101.
71. Kersten, W. Interaction of actinomycin C with constituents of nucleic acids. Biochem. Biophys. Acta. 1961, 47, 610-611.
72. Scholtissek, C; Rott, R. Binding of prophlavine to deoxyribonucleic asid and ribonucleic asid and it biologal significance. Nature, 1964, 204, 39-43.
73. Semmel, M; Huppert, J. Interaction in vitro entre actinomycin D in RNA ribosomes. Biochim. Biophys. Acta. 1965, 103, 702-704.
74. Reich, E. Actinomycin: correlation of structure and function of its complexes with purines and DNA. Science. 1964, 143, 684-689.
75. Tamaoki, T; Mueller, G. The effects of actinomycin D and puromycin on the formation of ribosome in Hela cells. Biochem. Biophys. Acta. 1965, 108, 73-80.
76. Schwartz, H; Garofalo, M. Degradation of RNA in liver of rats treated with actinomycin D. Mol. Pharmacol. 1967, 3, 1-8.
77. Khan, MM; Lindell, TJ. Actinomycin D binds with highest affinity to nonribosomal DNA. J. Biol. Chem. 1980, 25, 3581-3584.
78. Milko, E; Egorov, N; Vuitsik, E. Comparison of the sensitivity of Rhodococcus rubropertinctus R, S and M variants to antibiotic action. Antibiot. Med. Biotekhnol. 1987, 32, 576-578.
79. Rusanova, E; Alekhov, T; Fedorova, G; Katrukha, G. Development of a new method for preparing biologically active compounds based on the typed strain Streptomyces werraensis. Prikl. Biokhim.Mikrobiol. 2000, 36, 312-316.
80. Kim, H; Nam, J; Han, M; Son, K; Choi, J; Kwon, B; Takusagawa, H; Huang, Y; Takusagawa F. Natural and synthetic analogues of actinomycin D as Grb2-SH2 domain blockers. Bioorg. Med. Chem. Lett. 2000, 3, 1455-1457.
81. Lackner, H; Bahner, I; Shigematsu, N; Pannell, L; Mauger, A. Structures of five components of the actinomycin Z complex from Streptomyces fradiae, two of which contain 4-chlorothreonine. J. Nat. Prod. 2000, 63(3), 352-356.
82. Amos, H; Kuhn, A; Schwartz, AJ. Protein synthesis in sonically damaged Escherichia coli. J. Bacteriol. 1967, 94, 232-240.
83. Goldstein, M; Hamm, K; Amrod, E. Incorporation of triated actinomycin D into drug-sensitive and drug-resistant HeLa cells. Science. 1966, 25(151), 1555-1556.
84. Perlman, D; Mauger, A; Weissbach, H. Microbial metabolism of actinomycins and other heterodetic antibiotic peptides. Biochem. Biophys. Res. Commun. 1966, 23, 513-518.
85. Perlman, D; Mauger, A; Weissbach, H. Microbial transformations of peptide antibiotics. I. Degradation of actinomycins by Actinoplanes species. Antimicrobial Agents. Chemother. 1966, 6, 581-586.
86. Orlova, TI. Antibiotics and transport properties of cell membranes. Antibiotiki, 1980, 25, 540-546.
87. Sobell, H; Jain, S; Sakore, T; Ponticello, G. Concerning the stereochemistry of actinomycin binding to DNA: an actinomycindeoxyguanosine crystalline complex. Cold. Spring. Harb. Symp. Quant. Biol. 1972, 36, 263-270.
88. Papahadjopoulos, D; Poste, G; Vail, W; Biedler, J. Use of lipid vesicles as carriers to introduce actinomycin D into resistant tumor cells. Cancer. Res. 1976, 36, 2988-2994.
89. Kedar, A; Mayhew, E; Moore, R; Williams, P; Murphy, G. Effect of actinomycin D-containing lipid vesicles on murine renal adenocarcinoma. J. Surg. Oncol. 1980, 15, 363-365.
90. Vugrin, D; Whitmore, W; Golbey, R. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program. J. Urol. 1982, 128, 1205-1208.
91. Melguizo, C; Prados, J; Marchal, JA; Aranega, AE; Alvarez, L; Aranega, A. Low concentrations of actinomycin D potentially cause therapeutic differentiation in human rhabdomyosarcoma cell line RD. Pathol. Res. Pract. 1996, 192, 188-194.
92. Takusagawa, F; Carlson, R; Weaver, R. Anti-leukemia selectivity in actinomycin analogues. Bioorg. Med. Chem. 2001, 9, 719-725.
93. Hendrix, M; Wagner, H; Thomson, S; Brothman, A; Lindell, T. Immunohistochemical localization of actinomycin D in human melanoma tumor cells. Anticancer Res. 1984, 4, 97-102.
94. Creasey, A; Doyle, L; Reynolds, M; Jung, T; Lin, L; Vitt, C. Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines. Cancer Res. 1987, 47(1) 145-149.
95. Levshin, LV; Saletskii, AM. Optical Methods for the Study of Molecular Systems. Molecular Spectroscopy. Moscow: MGU, 1994.
96. Lakowicz, J. Principles of Fluorescence Spectroscopy. N.-Y.: Kluwer, 1999.
97. Badea, M; Brand, L. Time-resolved fluorescence measurements. In: Methods Enzymol. 1979, v. 61, 378.
98. Bailey, E; Rollefson, R. The determination of the fluorescence lifetimes of dissolved substances by a phase shift method. J. Chem. Phys. 1953, 21, 1315.
99. Muller, A; Lumry, R; Kokubun, H. High-performance phase fluorimeter constructed from commercial subunits. Rev. Sci. Instrum. 1965, 36, 1214.
100. Bonch-Bruevich, AM; Kazarin, IM; Molchanov, VA; Shirokov, IV. Experimental phase fluorometer. Pribori i Technika Experimenta, 1959, 2, 53.
101. Bauer, R; Rozwadawski, M. A new type of fluorimeter. Bull. Acad. Pol. Sci. Ser. Instrum. 1965, 8, 365.
102. Vekshin, NL. Photonics of Biopolymers. Berlin: Springer, 2002.
103. Tsuboi, M. Infrared Ray Absorption. Tanpakushitsu: Kakusan Koso, 1965, 115-128.
104. Ito, K; Shimanouchi, T. Vibrational frequencies and modes of alphahelix. Biopolymers. 1970, 9, 383-399.
105. Ito, K; Katabuchi, H; Shimanouchi, T. Far-infrared bands of amino-acid residues with -helical and -form conformations. Nat. New Bio. 1972, 13, 42-43.
106. 106. Ito, K; Oya, M; Shimanouchi, T. Far-infrared spectra of copoly(amino acids). Biopolymers. 1972, 11, 1137-1148.
107. Hartman, K. The infrared spectra of some complexes of metal ions with nucleotides. Biochem. Biophys. Acta. 1967, 29, 192-195.
108. Hartman, K. The structure of water and the stability of the secondary structure in biological molecules. An infrared and proton magnetic resonance study. J. Phys. Chem. 1966, 70, 270-276.
109. Vekshin, NL. Migration of energy in DNA, estimated by fluorescence of intercalating dye. Z. Prikladnoi Spektroskopii, 1998, 65, 794-798.
110. Shabarchina, LI; Montrel, MM; Sukhorukov, GB; Savintsev, IV; Sukhorukov, BI. Obtaining of multi-layer films of DNA by method of step-by-step adsorption. Z. Fizicheskoi Chimii. 2000, 74, 2093-2100.
111. Vekshin, NL. Fluorescence Spectroscopy of Biomacromolecules. Pushchino: Photon-vek. 2008.
112. Breslauer, KJ. Extracting thermodynamic data from equilibrium melting curves for oligonucleotide order-disorder transitions. In: Methods Enzymol. 1995, 259, 221-242.
113. Duguid, JG; Bloomfield, VA. Electrostatic effects on the stability of condensed DNA in the presence of divalent cations. Biophys J. 1996, 70, 2838-2846.
114. Brown, C; Shafer, R. Kinetic studies of actinomycin D binding to mono-, oligo-, and polynucleotides. Biochemistry, 1987, 26, 277-282.
115. Lu, K; Prohovsky, E; Van Zandt, A. Vibrational modes of A-DNA, BDNA, and A-RNA backbones: an application of a green-function refinement procedure. Biopolymers 1977, 16, 2506-.
116. Sukhorukov, BI; Montrel, MM. Infrared and X-ray diffraction study of the effect of protonation of DNA on its B-to-A transition. Biosens. Bioelectron. 1990, 11, 913-922.
117. Chemical Encyclopedia (Ed. by Knunyants, IL). Moscow: Sovetskaya Entsiklopedia, 1988.
118. Sukhorukov, GB; Feigin, LA; Montrel, MM; Sukhorukov, BI. X-ray and infrared study of Langmiur-Blodgett films of the complexes between nucleic acids and aliphatic amines. Thin Solid Films. 1994, 259, 79-84.
119. Verweij, J., Schellens JHM, Loo TL, Pinedo HM. Cancer Chemotherapy and Biotherapy (Eds. Chabner, BA; Longo, DL). Philadelphia: Lippincott-Raven Publishers. 1996.
120. Shinomiya, M; Chu, W; Carlson, RG; Weaver, RF; Takusagawa, F. Structural, physical, and biological characteristics of RNA*DNA binding agent N8-actinomycin D. Biochemistry, 1995, 34, 8481-8491.
121. Rill, RL; Hecker, KH. Sequence-specific actinomycin D binding to single-stranded DNA inhibits HIV reverse transcriptase and other polymerases. Biochemistry, 1996, 35, 3525-3533.
122. Chiao, YC; Rao, KG; Hook, JW; Krugh, TR; Sengupta, SK. 7-Aminoactinomycin D complexes with deoxynucleotides as models for binding of the drug to DNA. Biopolymers. 1979, 18, 1749-1762.
123. Wadkins, RM; Jares-Erijman, EA; Klement, R; Ruediger, A; Jovin, TM. J. Mol. Biol. 1996, 262, 53-68.
124. Basu, J; Padhy, N; Mookerjee, A. An insight into the structure of DNA through melting studies. Indian J. Biochem. Biophys. 1990, 27(4), 202-208.
125. Pan, JX; Liu, Y; Zhang, SP; Tu, TC; Yao, SD; Lin, NY. Photodynamic action of actinomycin D: an EPR spin study. Biochim Biophys. Acta. 2001, 1527, 1-3.
126. Gill, JE; Jotz, MM; Young, SG; Modest, EJ; Sengupta SK. 7-Aminoactinomycin D as a cytochemical probe. I. Spectral properties. J. Histochem. Cytochem. 1975, 23, 793-799.
127. Smulevich, G; Angeloni, L; Marzocchi, MP. Raman excitation profiles of actinomycin D. Biochem. Biophys. Acta. 1980, 610, 384-391.
128. Kamitory, S; Takusagawa, F. Crystal structure of the 2:1 complex between d(GAAGCTTC) and the anti-cancer drug actinomycin D. J. Mol. Biol. 1992, 225, 445-456.
129. Kamitory, S; Takusagawa, F. Multiple binding models of anti-cancer drug actinomycin D: X-ray, molecular modeling, and spectroscopic studies of d(GAAGCTTC)-actinomycin D complexes and its host DNA. J. Am. Chem. Soc. 1994, 116, 4154-4165.
130. Meienhofer, J; Atherton, E. Structure-Activity Relationship Among the Semisynthetic Antibiotics. NY: Perlman Ed., Academic Press Inc., 1977.
131. Gale, EF; Cunliffe, E; Reynolds, PE; Richmond, MH; Waring, MJ. The Molecular Basis of Antibiotic Action. London: John Wiley and Sons, 1981.
132. Liu, W; Vu, HM; Kearns DR. 1H NMR studies of a 17-mer DNA duplex. BBA, 2002, 1574, 93-99.
133. Qu, X; Ren, J; Riccelly, PV; Benight, AS; Chaires, JB. Enthalpy/entropy compensation: Influence of DNA flanking sequence on the binding of 7- amino actinomycin D to its primary binding site in short DNA duplexes. Biochemistry. 2003, 42, 11960-11967.
134. Hou, MH; Robinson, H; Gao, YG; Wang, AHJ. Crystal structure of actinomycin D bound to the CTG triplet repeat sequences linked to neurological deseases. Nucl. Acid Res. 2002, 30, 4910-4917.
135. Frederick, CA; Quigley, GJ; Teng, MK; Coll, M; Van der Marel, GA; Van Boom, JH; Rich, A; Wang, AH. Molecular structure of an A-DNA decamer d(ACCGGCCGGT). Eur. J. Biochem. 1989, 181, 295-307.
136. Quigley, GJ; Wang, AHJ; Ughetto, G; Van der Marel, GA; Boom, JH; Rich, A. Molecular structure of an anti-cancer drug-DNA complex: Daunomycin plus d(CpGpTpApCpG). PNAS USA, 1980, 77, 7204-7208.
137. Jares-Erijman, EA; Klement, R; Machinek, R; Wadkins, RM; Marky, LA; Kankia, BI; Jovin, TM. Binding of actinomycin D to singlestranded DNA. Nucleosides and Nucleotides, 1997, 16, 661-667.
138. Chen, FM; Sha, F; Chin, KH. The nature of actinomycin D binding to d(AACCAXYG) sequence motif. Nucl. Acid Res. 2004, 32, 271-277.
139. Goodisman, J; Rehfuss, R; Wang, B; Dabrowiak, JC. Site-specific binding constants for actinomycin D on DNA determined from footprinting studies. Biochemistry. 1992, 31, 1046-1058.
140. Chen, FM; Sha, F; Chin, KH; Chou, SH. Binding of actinomycin D to single-stranded DNA of sequence motif d(TGTCTnG) and d(TGTnGTCT). Biophys. J. 2003, 84, 432-439.
141. Ren, J; Jenkins, TC; Chaires, JB. Energetics of DNA intercalation reactions. Biochem. 2000, 39, 8439-8447.
142. Quadrifoglio, F; Ciana, A; Crescenzi, V. On the interaction between actinomycin D and DNA. Biopolymers. 1976, 15, 595-597.
143. Benight, AS; Gallo, FJ; Paner, TM; Bishop, KD; Faldasz, FD; Lane, MJ. Advances in Biophysical Chemistry. Greenwich: JAI Press Inc., 1995, 5, 1-55.
144. Sanger, W. Principles of Nucleic Acid Structure. Springer-Verlag, 1984.
145. Lee, CH; Mizusaa, H; Kakefuda, T. Unwinding of double-stranded DNA helix by dehydration. PNAS USA, 1981, 78, 2838-2842.
146. Neto, JR; Colombo, MF. Water regulation of actinomycin-D binding to DNA: The interplay among drug affinity, DNA long-range conformation, and hydration. Biopolymers. 2000, 53, 46-59.
147. Wyman, J; Gill, SJ. Binding and Linkage: Functional Chemistry of Biological Macromolecules. Univ. Science Books, Mill Valley, CA, 1981.
148. Rentzeperis, D; Kupke, DW; Marky, LA. Volume changes correlate with entropies and enthalpies in formation of nucleic acid homoduplexes: differential hydration of A and B conformations. Biopolymers. 1993, 33, 117-125.
149. Bailey, SA; Graves, DE; Rill, R; Marsch, G. Influence of DNA base sequence on the binding energetics of actinomycin D. Biochemistry. 1993, 32, 5881-5887.
150. Record, MT; Ha, JH; Fisher, MA. Analysis of equilibrium and kinetic measurements to determine thermodynamic origins of stability and specificity and mechanism of formation of site-specific complexes between proteins and helical DNA. Methods Enzymol, 1991, 208, 291-344.
151. Schreiera, S; Malheirosb, SVP; De Paulab, E. Surface active drugs: selfassociation and interaction with membranes and surfaction with membranes and surfactants. Physicochemical and biological aspects. BBA-Biomembranes. 2000, 1508, 1, 210-234.
152. Hashimoto, Y; Sugawara, M; Masuko, T; Hojo, H. Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumorspecific monoclonal immunoglobulin M antibody. Cancer Res. 1983, 43, 5328-5334.
153. Cheung, SC; Medoff, G; Schlessinger, D; Kobayashi, GS. Response of yeast and mycelial phase of Histoplasma capsulatum to amorphotericin B and actinomycin D. Antimicrob. Agents Chemother. 1975, 8, 498-503.
154. Kinjo, M; Nishimura, G; Koyama, T; Rigler, R. Single-molecule analysis of restriction DNA fragments using fluorescence correlation spectroscopy. Anal. Biochem., 1998, 260, 166-172.
155. 155. Sailer, BL; Nastasi, AJ; Valdez, JG; Steinkamp, JA; Crissman, HA. Differential effects of deuterium oxide on the fluorescence lifetimes and intensities of dyes with different modes of binding to DNA. J. Histochem. Cytochem, 1997, 45, 165-175.
156. Maeda, Y; Nunomura, K; Ohtsubo, E. Differential scanning calorimetric study of the effect of intercalators and other kinds of DNA-binding drugs on the stepwise melting of plasmid DNA. J. Mol. Biol. 1990, 215, 321-329.
157. Tai, JC; Craig, WS; Gaber, BP. On the electronic spectrum of actinomycin D. J. Am. Chem. Soc. 1976, 98, 7925-7927.
158. Auer, HE; Pawlowski-Konopnicki, BE; Chiao, YCC; Krugh, TR. Resolution of electronic absorption bands and nucleotide binding process in actinomycin D. Biopolymers. 1978, 17, 1891-1911.
159. Xodo, LE; Manzini, G; Quadrifoglio, F; Yathindra, N; Van der Marel, GA; Van Boom, JH. A facile duplex-hairpin interconversion through a cruciform intermediate in a linear DNA fragment. J. Mol. Biol. 1989, 205, 777-781.
160. Kurahashi, H; Inagaki, H; Yamada, K; Ohye, T; Taniguchi, M; Emanuel, BS; Toda, T. Cruciform DNA structure underlies the etiology for palindrome-mediated human chromosomal translocations. J. Biol. Chem. 2004, 279, 35377-35383.
161. Auer, HE; Pawlowski-Konopnicki, BE; Krugh, TR. The absorption spectrum of actinomycin D. Evidence for three transitions in the visible band. FEBS Letters, 1977, 73, 167-170.
162. Chaires JB; Dattagupta, N; Crothers, DM. Self-associacion of daunomycin. Biochemistry. 1982, 3927-3932.
163. Gause, GF; Dudnik, UV. Anti-tumor Antibiotics. Moscow: Meditsina, 1987.
164. Bachur, NR; Gordon, SL; Gee, MV. A General Mechanism for Microsomal Activation of Quinone Anti-cancer Agents to Free Radicals. Cancer Res. 1978, 38, 1745-1750.
165. Nakasawa, H; Chou Fery-te, E., Andrew, P. Determination of teratogenic potential. J. Org. Chem. 1981, 46, 1493-1496.
166. Cheung, S.C., Medoff G., Schlessinger D. Response of yeast and mycelial phase of Histoplasma capsulatum to amorphotericin B and actinomycin D. Antimicrob. Agents Chemother. 1975, 8, 498-503.
167. Nurminen, ML; Nittynen, L; Korpela, R; Vapaatalo, H. Coffee, caffeine and blood pressure: a critical review. Eur. J. Clin. Nutr. 1999, 53, 891-899.
168. Brauer, LH; Buican, B; De Wit, H. Caffeine effects on cells, DNA and apoptosis. Behav. Pharmacol. 2002, 5, 111-118.
169. Florensa, R; Bachs, O; Agell, N. ATM/ATR-independent inhibition of cyclin B accumulation in response to hydroxyurea in nontransformed cell lines is altered in tumor cell lines. Oncogene, 2003, 22, 8283-8292.
170. Selby, CP; Sancar, A. Transcription preferentially inhibits nucleotide excision repair of the template DNA strand in vitro. J. Biol. Chem., 1990, 265, 21330-21336.
171. Marheineke, K; Hyrien, O. Control of replication origin density and firing time in xenopus egg extracts: J. Biol. Chem, 2004, 279, 28071-28081.
172. Ito, T; Hashimoto, Y; Tanaka, E; Kan, T; Tsunoda, S; Sato, F; Higashiyama, M; Okumura, T; Shimada, Y. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo. Clin Cancer Res. 2006, 12, 1308-1316.
173. Collins, RO; Thomas, RC. The effect of calcium pump inhibitors on the response of intracellular calcium to caffeine in snail neurones. Cell Calcium., 2001, 1, 41-48.
174. Kennedy, HJ; Thomas, RC. Intracellular calcium and its sodiumindependent regulation in voltage-clamped snail neurones. J. Physiol, 1995, 484, 533-548.
175. Mironov, SL; Usachev, JM. Caffeine affects Ca2+ uptake and Ca2+ release from intracellular stores: Fura-2 measurements in isolated snail neurons. Neurosci. Lett., 1991, 123, 200-202.
176. Orkand, RK; Thomas, RC. Effects of low doses of caffeine on [Ca 21]i in voltage-clamped snail (Helix aspersa) neurones. J. Physiol. 1995, 489, 19-28.
177. Origlia-Luster, ML; Patterson, BA; Woolleya, EM. Thermodinamics of dissociation. J. Chem. Thermodyn. 2002, 34, 1909-1921.
178. Davies DB; Veselkov DA; Djimant, LN; Veselkov, AN. Heteroassociation of caffeine and aromatic drugs and their competitive binding with a DNA oligomer. Eur. Biophys. J. 2001, 30, 354-366.
179. Shestopalova, AV. Computer modeling of association of caffeine and derivatives of actinocin in aqueous solutions. Biofizika, 2006, 51, 389-401.
180. Piosik, J; Zdunek, M; Kapuscinski, J. The modulation by xanthines of the DNA-damaging effect of polycyclic aromatic agents. Part II. The stacking complexes of caffeine with doxorubicin and mitoxantrone. Biochem. Pharm. 2002, 63, 635-646.
181. Lyles, MB; Cameron, IL. Interactions of the DNA intercalator acridine orange, with itself, with caffeine, and with double stranded DNA. Biophys. Chem. 2002, 96, 53-76.
182. Lyles, MB; Cameron, IL; Rawls, HR. Structural basis for the binding affinity of xanthines with the DNA intercalator acridine orange. J. Med. Chem. 2001, 44, 5650-5660.
183. Savintsev, IV; Vekshin, NL. Formation of complexes of actinomycins with DNA in solutions and films. Prikladn. Biokchim. Microbiol., 2004, 40, 421-428.
184. Bitehtina, MA; Vekshin, NL. Caffeine clusters as transmitters of actinomycin antibiotics to DNA in solution Bioorganich. Chkimiya, 2008, 34(2), 256-261.
185. Vekshin, NL; Kovalev AE. Prompt non-stacking binding of actinomycin D to hairpin oligonucleotide HP1 and slow redistribution from HP1 to DNA. J. Biochem. 2006, 140, 185-191.
186. Vekshin, NL. Cluster melting of DNA-actinomycin complexes. Bifizika, 2010, in press.
187. Muller, W; Crothers, DM. Interactions of heteroaromatic compounds with nucleic acids. 1. The influence of heteroatoms and polarizability on the base specificity of intercalating ligands. Eur. J. Biochem. 1975, 54, 267- 277.
188. Mayfield, JE. A comparison of the differential DNA melting profiles with the CsCl density profiles of DNA from Escherichia coli, cow, mouse, rat and chicken. Biochim. Biophys. Acta, 1977, 15, 97-101.
189. Melchior, WB; Beland, FA. Melting of satellite DNA fractions. Chemico-Biological Interactions. 1984, 49, 177-187.
190. Akhrem, AA; Andrianov, VT; Vlasov, AP; Korolev, NI; Kuznetsov, IA. Micro-calorimetric melting of DNA.. Molekularnaya Biologia, 1985, 19, 623-628.
191. Vlasov, AP; Yakhontova, LI; Andrianov, VT. Effect of ionic strength, concentrations and other conditions at equilibrium or disequilibrium melting in micro-calorimetry on DNA. Biofizika, 1991, 36, 437-440.
192. Chalikian, TV; Volker, J; Plum, GE; Breslauer, KJ. A more unified picture for the thermodynamics of nucleic acid duplex melting: a characterization by calorimetric and volumetric techniques. Proc. Natl Acad. Sci. USA. 1999, 96, 7853-7858.
193. Volker, J; Blake, RD; Delcourt, SG; Breslauer, KJ. High-resolution calorimetric and optical melting profiles of DNA plasmids: Resolving contributions from intrinsic melting domains and specifically designed inserts. Biopolymers, 1999, 50, 303-318.
194. Fox, KR; Waring, MJ. Kinetic evidence for redistribution of actinomycin molecules between potential DNA-binding sites. Eur. J. Biochem. 1984, 145, 579-586.
195. Kovalev, AE; Yakovenko, AA; Vekshin, NL. Investigation of 7-aminoactinomycin D and DNA by fluorescence correlated microscopy, Biofizika, 2004, 49, 1030-1037.
196. Vekshin, NL. Fluorescence cells with diagonal plate. Photonics. 2007, 4, 29-30.
197. Vekshin, NL. Hairpin oligonucleotides as carriers of actinomycins to the dissolved and nuclear DNA. In: Reception and Intracellular Signaling. Pushchino: IBC RAS, 2007, 288-290.
198. Bitehtina, MA; Vekshin NL. 7 amino-actinomycin as a fluorescent probe to un-twisting and denaturation of DNA. Bioorganicheskaya Chkimiya, 2008, 34, 781-785.
199. Salamon, DS. Matrix systems for drug delivery and method of its production. Patent of Russian Federation No 2005100840/04.
200. Zhou, T. Antibody, which is selective to receptor of a ligand, inducing apoptosis and associated with necrosis. Patent of Russian Federation No 2004116475.
201. Vincent, PU. Cjmposition, containing derivatives of aryl-urea in combination with cytotoxic or cytostatic agent; method of treating of malignancies and method for inhibitions of proliferation of tumor cells. Patent of Russian Federation No 2004120785.
202. Pharma, M. Application of alkaloids of lamellarin in methods of treatment. Patent of Russian Federation No 98101364.
203. Gusev, SA. Method for the preparation for drug delivery. Patent of Russian Federation No 96107922/14.
204. Gold, DA. Monoclonal antibody RAM4 and its application for the diagnosis and treatment of pancreatic cancer. Patent of Russian Federation No 2005100777/13.
205. Charman, W. Advanced drug delivery system. Patent of Russian Federation No 2006106173/14.
206. Bock, RE. Drug delivery system for hydrophobic medicine. Patent of Russian Federation No 2003132694/15.
207. Feldstein, MM. Covalent and non- covalent cross-linking of hydrophylic polymers and adhesive compositions. Patent of Russian Federation No 2005131950.
208. Holmberg, K. New itself-emulgating drug delivery system. Patent of Russian Federation No 2002122745/15.
209. Ferreira, P. Anhydrous single carriers and products. Patent of Russian Federation No 2005133427/15.
210. Walker, EH. Highly specific pharmacological anti-tumor drug system, synthesis of drugs and method of simulation of medicines. Patent of Russian Federation No 2005121571.
211. Remington, KA. Substance. Patent of Russian Federation No 2004109228/15.
212. Bess, J. Patent of Russian Federation No 2004122919.
213. Vekshin, NL. Delivery of hetero-cyclic antibiotics to cancer cells using nano-nucleotide pharmacosomes. Patent of Russian Federation No 2372073.
214. Saito, M; Kobayashi, M; Iwabuchini, SI; Motita, Y; Takamura, Y; Tamiya, E. J. Biochem. 2004, 36, 813-823.
215. Vekshin, NL; Savintsev, IV. Hairpin oligonucleotides as vectors for actinomycins. Biofizika, 2009, 54, 1037-1041.